Page 17

Febrero 2016

Art ículos de Investigaci ón 151 12. Buyse M, Piedbois P. Should Dukes’ B patients receive adjuvant therapy? A statistical perspective. Semin Oncol 2001; 28 (1 Suppl 1): 20-4. 13. Figueredo A, Coombes ME, Mukherjee S. Adjuvant therapy for completely resected stage II colon cancer. Cochrane Database Syst Rev 2008 (3): CD005390. 14. NCCN Clinical Practice Guidelines in Oncology: Colon Cancer. Version 1 http://www.nccn.org/professionals/ physician_gls/f_guidelines.asp2014 cited 2014 Mayo 26. 15. Labianca R, Nordlinger B, Beretta GD, Mosconi S, Mandalà M, Cervantes A, et al. Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013; 24 Suppl 6: vi64-72. 16. Twelves C, Wong A, Nowacki MP, Abt M, Burris H, Carrato A, et al. Capecitabine as adjuvant treatment for stage III colon cancer. N Engl J Med 2005; 352 (26): 2696-704. 17. Haller DG, Tabernero J, Maroun J, de Braud F, Price T, Van Cutsem E, et al. Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer. J Clin Oncol 2011; 29 (11): 1465-71. 18. Registro Civil e identificación de Chile 2013. https:// http://www.registrocivil.cl/OficinaInternet/servlet/HomeVenta on October 10, 2013 cited 2013 October 10. 19. Sobin L, Gospodarowicz M, Wittekind C. TNM classification of malignant tumours. New York: Wiley-Blackwell 2009. 20. O’Connell MJ, Mailliard JA, Kahn MJ, Macdonald JS, Haller DG, Mayer RJ, et al. Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. J Clin Oncol 1997; 15 (1): 246-50. 21. de Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000; 18 (16): 2938-47. 22. O’Connor ES, Greenblatt DY, Lo Conte NK, Gangnon RE, Liou JI, Heise CP, et al. Adjuvant chemotherapy for stage II colon cancer with poor prognostic features. J Clin Oncol 2011; 29 (25): 3381-8. 23. Ribic CM, Sargent DJ, Moore MJ, Thibodeau SN, French AJ, Goldberg RM, et al. Tumor microsatellite instability status as a predictor of benefit from fluorouracil based adjuvant chemotherapy for colon cancer. N Engl J Med 2003; 349 (3): 247-57. 24. Des Guetz G, Schischmanoff O, Nicolas P, Perret GY, Morere JF, Uzzan B. Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysis. Eur J Cancer 2009; 45 (10): 1890-6. 25. Gryfe R, Kim H, Hsieh ET, Aronson MD, Holowaty EJ, Bull SB, et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 2000; 342 (2): 69-77. 26. Gray R, Barnwell J, McConkey C, Hills RK, Williams NS, Kerr DJ, et al. Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet 2007; 370 (9604): 2020-9. 27. O’Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 2004; 96 (19): 1420-5. 28. Sargent D, Sobrero A, Grothey A, O’Connell MJ, Buyse M, Andre T, et al. Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol 2009; 27 (6): 872-7. 29. Figueredo A, Charette ML, Maroun J, Brouwers MC, Zuraw L. Adjuvant therapy for stage II colon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care’s gastrointestinal cancer disease site group. J Clin Oncol 2004; 22 (16): 3395-407. 30. Bannura G, Castillo C, Cumsille M, Barrera A. Resultados de la quimioterapia adyuvante en cáncer de colon. Rev Chilena de Cirugía p. 403-9. 31. Sanoff HK, Carpenter WR, Stürmer T, Goldberg RM, Martin CF, Fine JP, et al. Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years. J Clin Oncol 2012; 30 (21): 2624-34. Quimioterapia adyuvante en cáncer de colon - S. Mondaca et al Rev Med Chile 2016; 144: 145-151


Febrero 2016
To see the actual publication please follow the link above